{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:36:15Z","timestamp":1781109375476,"version":"3.54.1"},"reference-count":45,"publisher":"National Academy of Sciences","issue":"21","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2012,5,22]]},"abstract":"<jats:p>\n                    Metastasis from primary tumors remains a major problem for tumor therapy. In the search for markers of metastasis and more effective therapies, the tumor metabolome is relevant because of its importance to the malignant phenotype and metastatic capacity of tumor cells. Altered choline metabolism is a hallmark of cancer. More specifically, a decreased glycerophosphocholine (GPC) to phosphocholine (PC) ratio was reported in breast, ovarian, and prostate cancers. Improved strategies to exploit this altered choline metabolism are therefore required. However, the critical enzyme cleaving GPC to produce choline, the initial step in the pathway controlling the GPC\/PC ratio, remained unknown. In the present work, we have identified the enzyme, here named EDI3 (endometrial differential 3). Purified recombinant EDI3 protein cleaves GPC to form glycerol-3-phosphate and choline. Silencing EDI3 in MCF-7 cells decreased this enzymatic activity, increased the intracellular GPC\/PC ratio, and decreased downstream lipid metabolites. Downregulating EDI3 activity inhibited cell migration via disruption of the PKC\u03b1 signaling pathway, with stable overexpression of EDI3 showing the opposite effect. EDI3 was originally identified in our screening study comparing mRNA levels in metastasizing and nonmetastasizing endometrial carcinomas. Both Kaplan\u2013Meier and multivariate analyses revealed a negative association between high EDI3 expression and relapse-free survival time in both endometrial (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; 0.001) and ovarian (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.029) cancers. Overall, we have identified EDI3, a key enzyme controlling GPC and choline metabolism. Because inhibition of EDI3 activity corrects the GPC\/PC ratio and decreases the migration capacity of tumor cells, it represents a possible target for therapeutic intervention.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1117654109","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T22:59:15Z","timestamp":1336517955000},"page":"8155-8160","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":83,"title":["Choline-releasing glycerophosphodiesterase EDI3 drives tumor cell migration and metastasis"],"prefix":"10.1073","volume":"109","author":[{"given":"Joanna D.","family":"Stewart","sequence":"first","affiliation":[{"name":"Leibniz Research Centre for Working Environment and Human Factors (IfADO), University of Dortmund, 44139 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Marchan","sequence":"additional","affiliation":[{"name":"Leibniz Research Centre for Working Environment and Human Factors (IfADO), University of Dortmund, 44139 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela S.","family":"Lesjak","sequence":"additional","affiliation":[{"name":"Leibniz Research Centre for Working Environment and Human Factors (IfADO), University of Dortmund, 44139 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Lambert","sequence":"additional","affiliation":[{"name":"Interface Processes, Leibniz-Institut fuer Analytische Wissenschaften (ISAS), 44227 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Hergenroeder","sequence":"additional","affiliation":[{"name":"Interface Processes, Leibniz-Institut fuer Analytische Wissenschaften (ISAS), 44227 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Ho","family":"Lau","sequence":"additional","affiliation":[{"name":"Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector C.","family":"Keun","sequence":"additional","affiliation":[{"name":"Biomolecular Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London SW7 2AZ, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, 93053 Regensburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Schiller","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Medical Physics and Biophysics, University of Leipzig, 04107 Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Eibisch","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Medical Physics and Biophysics, University of Leipzig, 04107 Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hedberg","sequence":"additional","affiliation":[{"name":"Chemical Biology, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Chemical Biology, Max Planck Institute of Molecular Physiology, 44227 Dortmund, Germany;"},{"name":"Fakultaet Chemie, Lehrbereich Chemische Biologie, Technische Universitaet Dortmund, 44227 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehart","family":"Lausch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Freiburg University Medical Center, 79106 Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berno","family":"Tanner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Oranienburg Clinic, 16515 Oranienburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Charite University Hospital, 13353 Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Sagemueller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Duesseldorf University Hospital, 40225 Duesseldorf, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Staude","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Rostock, 18057 Rostock, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Steiner","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Gesundheits-und Pflegezentrum Ruesselsheim Gemeinn\u00fctzige GmbH, 65428 Ruesselsheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[{"name":"Leibniz Research Centre for Working Environment and Human Factors (IfADO), University of Dortmund, 44139 Dortmund, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2012,5,8]]},"reference":[{"key":"e_1_3_3_1_2","first-page":"80","article-title":"Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells","volume":"59","author":"Aboagye EO","year":"1999","unstructured":"EO Aboagye, ZM Bhujwalla, Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59, 80\u201384 (1999).","journal-title":"Cancer Res"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10659"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3829"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1146"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bioeng.7.060804.100411"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/cr9004007"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-3833"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.1940050518"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22293"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205556"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)00920-8"},{"key":"e_1_3_3_13_2","first-page":"3112","article-title":"In vivo antitumor activity of choline kinase inhibitors: A novel target for anticancer drug discovery","volume":"59","author":"Hern\u00e1ndez-Alcoceba R","year":"1999","unstructured":"R Hern\u00e1ndez-Alcoceba, F Fern\u00e1ndez, JC Lacal, In vivo antitumor activity of choline kinase inhibitors: A novel target for anticancer drug discovery. Cancer Res 59, 3112\u20133118 (1999).","journal-title":"Cancer Res"},{"key":"e_1_3_3_14_2","first-page":"1375","article-title":"Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method","volume":"16","author":"Katz-Brull R","year":"1996","unstructured":"R Katz-Brull, H Degani, Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. Anticancer Res 16, 1375\u20131380 (1996).","journal-title":"Anticancer Res"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.12.008"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(00)00612-1"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(03)00229-8"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(94)90175-9"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1994.229"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1271\/bbb.70062"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.106708"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0805496105"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.2766"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)00989-4"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.317"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)40184-1"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-0731com"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M707416200"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25402"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1143"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1411571"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.140"},{"key":"e_1_3_3_34_2","first-page":"1099","article-title":"Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer","volume":"50","author":"Narayan P","year":"1991","unstructured":"P Narayan, R Dahiya, Alterations in sphingomyelin and fatty acids in human benign prostatic hyperplasia and prostatic cancer. Biomed Biochim Acta 50, 1099\u20131108 (1991).","journal-title":"Biomed Biochim Acta"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2009.02.009"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21669"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0131"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.14.3909"},{"key":"e_1_3_3_39_2","volume-title":"Cancer Facts and Figures 2010","author":"American Cancer Society","year":"2010","unstructured":"; American Cancer Society Cancer Facts and Figures 2010 (American Cancer Society, Atlanta, 2010)."},{"key":"e_1_3_3_40_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/ijgc-00009577-200303000-00017","article-title":"Multivariate independent prognostic factors in endometrial carcinoma: A clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University","volume":"13","author":"Steiner E","year":"2003","unstructured":"E Steiner, et al., Multivariate independent prognostic factors in endometrial carcinoma: A clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 13, 197\u2013203 (2003).","journal-title":"Int J Gynecol Cancer"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61737-985-7_19"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0912059107"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2008.07.008"},{"key":"e_1_3_3_44_2","first-page":"188","article-title":"Characterization of c-kit expression in small cell lung cancer: Prognostic and therapeutic implications","volume":"9","author":"Micke P","year":"2003","unstructured":"P Micke, et al., Characterization of c-kit expression in small cell lung cancer: Prognostic and therapeutic implications. Clin Cancer Res 9, 188\u2013194 (2003).","journal-title":"Clin Cancer Res"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.1229"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1117654109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T12:30:56Z","timestamp":1743078656000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1117654109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,8]]},"references-count":45,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5,22]]}},"alternative-id":["10.1073\/pnas.1117654109"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1117654109","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,8]]},"assertion":[{"value":"2012-05-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}